And Still They Come Over Troubled Waters: Can Asia’s Third-Generation EGFR Tyrosine Kinase Inhibitors (Furmonertinib, Aumolertinib, Rezivertinib, Limertinib, Befotertinib, SH-1028, and Lazertinib) Affect Global Treatment of EGFR+ NSCLC

Autor:	Sally C M, Lau, Sai-Hong Ignatius, Ou
Rok vydání:	2022
Předmět:	Pulmonary and Respiratory Medicine Acrylamides Asia Indoles Lung Neoplasms Morpholines ErbB Receptors Pyrimidines Oncology Carcinoma Non-Small-Cell Lung Mutation Humans Pyrazoles Protein Kinase Inhibitors
Zdroj:	Journal of Thoracic Oncology. 17:1144-1154
ISSN:	1556-0864
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac462685a94884622fb57ffcb59e4507 https://doi.org/10.1016/j.jtho.2022.08.016 Zobrazit plný text záznamu